Healthy volunteers help uncover drug interaction risks for evobrutinib
NCT ID NCT05064488
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study looked at how the experimental drug evobrutinib affects the way the body handles four common medications: digoxin, metformin, rosuvastatin, and sumatriptan. Forty healthy adults took evobrutinib along with these drugs so researchers could measure changes in drug levels and safety. The goal was to understand potential drug interactions, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvisan GmbH
Neu-Ulm, 89231, Germany
Conditions
Explore the condition pages connected to this study.